Sodium pentaborate pentahydrate

DRUG3 trials

Sponsors

Tabriz University of Medical Sciences

Conditions

Alzheimer DiseaseOsteoporosis, PostmenopausalOverweight and Obesity

Phase 1

Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity

CompletedNCT05741606

Tabriz University of Medical SciencesOverweight and Obesity

Start: 2024-07-01End: 2025-01-21Updated: 2026-08-11

Phase 2

Efficacy of OsteoBor in Postmenopausal Osteoporosis

Not yet recruitingNCT06809816

Tabriz University of Medical SciencesOsteoporosis, Postmenopausal

Start: 2025-03-01End: 2025-09-01Target: 30Updated: 2025-02-05

The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease

Not yet recruitingNCT06840054

Tabriz University of Medical SciencesAlzheimer Disease

Start: 2025-05-01End: 2026-01-30Target: 30Updated: 2025-02-21